Cargando…

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation

BACKGROUND: Recent work indicates that the airways of persons with cystic fibrosis (CF) typically harbor complex bacterial communities. However, the day-to-day stability of these communities is unknown. Further, airway community dynamics during the days corresponding to the onset of symptoms of resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmody, Lisa A, Zhao, Jiangchao, Kalikin, Linda M, LeBar, William, Simon, Richard H, Venkataraman, Arvind, Schmidt, Thomas M, Abdo, Zaid, Schloss, Patrick D, LiPuma, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381400/
https://www.ncbi.nlm.nih.gov/pubmed/25834733
http://dx.doi.org/10.1186/s40168-015-0074-9
_version_ 1782364448304922624
author Carmody, Lisa A
Zhao, Jiangchao
Kalikin, Linda M
LeBar, William
Simon, Richard H
Venkataraman, Arvind
Schmidt, Thomas M
Abdo, Zaid
Schloss, Patrick D
LiPuma, John J
author_facet Carmody, Lisa A
Zhao, Jiangchao
Kalikin, Linda M
LeBar, William
Simon, Richard H
Venkataraman, Arvind
Schmidt, Thomas M
Abdo, Zaid
Schloss, Patrick D
LiPuma, John J
author_sort Carmody, Lisa A
collection PubMed
description BACKGROUND: Recent work indicates that the airways of persons with cystic fibrosis (CF) typically harbor complex bacterial communities. However, the day-to-day stability of these communities is unknown. Further, airway community dynamics during the days corresponding to the onset of symptoms of respiratory exacerbation have not been studied. RESULTS: Using 16S rRNA amplicon sequencing of 95 daily sputum specimens collected from four adults with CF, we observed varying degrees of day-to-day stability in airway bacterial community structures during periods of clinical stability. Differences were observed between study subjects with respect to the degree of community changes at the onset of exacerbation. Decreases in the relative abundance of dominant taxa were observed in three subjects at exacerbation. We observed no relationship between total bacterial load and clinical status and detected no viruses by multiplex PCR. CONCLUSION: CF airway microbial communities are relatively stable during periods of clinical stability. Changes in microbial community structure are associated with some, but not all, pulmonary exacerbations, supporting previous observations suggesting that distinct types of exacerbations occur in CF. Decreased abundance of species that are dominant at baseline suggests a role for less abundant taxa in some exacerbations. Daily sampling revealed patterns of change in microbial community structures that may prove useful in the prediction and management of CF pulmonary exacerbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-015-0074-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4381400
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43814002015-04-02 The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation Carmody, Lisa A Zhao, Jiangchao Kalikin, Linda M LeBar, William Simon, Richard H Venkataraman, Arvind Schmidt, Thomas M Abdo, Zaid Schloss, Patrick D LiPuma, John J Microbiome Research BACKGROUND: Recent work indicates that the airways of persons with cystic fibrosis (CF) typically harbor complex bacterial communities. However, the day-to-day stability of these communities is unknown. Further, airway community dynamics during the days corresponding to the onset of symptoms of respiratory exacerbation have not been studied. RESULTS: Using 16S rRNA amplicon sequencing of 95 daily sputum specimens collected from four adults with CF, we observed varying degrees of day-to-day stability in airway bacterial community structures during periods of clinical stability. Differences were observed between study subjects with respect to the degree of community changes at the onset of exacerbation. Decreases in the relative abundance of dominant taxa were observed in three subjects at exacerbation. We observed no relationship between total bacterial load and clinical status and detected no viruses by multiplex PCR. CONCLUSION: CF airway microbial communities are relatively stable during periods of clinical stability. Changes in microbial community structure are associated with some, but not all, pulmonary exacerbations, supporting previous observations suggesting that distinct types of exacerbations occur in CF. Decreased abundance of species that are dominant at baseline suggests a role for less abundant taxa in some exacerbations. Daily sampling revealed patterns of change in microbial community structures that may prove useful in the prediction and management of CF pulmonary exacerbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-015-0074-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-01 /pmc/articles/PMC4381400/ /pubmed/25834733 http://dx.doi.org/10.1186/s40168-015-0074-9 Text en © Carmody et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Carmody, Lisa A
Zhao, Jiangchao
Kalikin, Linda M
LeBar, William
Simon, Richard H
Venkataraman, Arvind
Schmidt, Thomas M
Abdo, Zaid
Schloss, Patrick D
LiPuma, John J
The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
title The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
title_full The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
title_fullStr The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
title_full_unstemmed The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
title_short The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
title_sort daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381400/
https://www.ncbi.nlm.nih.gov/pubmed/25834733
http://dx.doi.org/10.1186/s40168-015-0074-9
work_keys_str_mv AT carmodylisaa thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT zhaojiangchao thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT kalikinlindam thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT lebarwilliam thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT simonrichardh thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT venkataramanarvind thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT schmidtthomasm thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT abdozaid thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT schlosspatrickd thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT lipumajohnj thedailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT carmodylisaa dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT zhaojiangchao dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT kalikinlindam dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT lebarwilliam dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT simonrichardh dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT venkataramanarvind dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT schmidtthomasm dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT abdozaid dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT schlosspatrickd dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation
AT lipumajohnj dailydynamicsofcysticfibrosisairwaymicrobiotaduringclinicalstabilityandatexacerbation